Merz, Valeria
 Distribuzione geografica
Continente #
NA - Nord America 1.830
EU - Europa 1.808
AS - Asia 1.255
SA - Sud America 153
AF - Africa 41
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.093
Nazione #
US - Stati Uniti d'America 1.786
RU - Federazione Russa 773
SG - Singapore 449
CN - Cina 369
IT - Italia 282
DE - Germania 174
GB - Regno Unito 153
VN - Vietnam 139
BR - Brasile 123
HK - Hong Kong 113
IE - Irlanda 85
FR - Francia 82
SE - Svezia 82
FI - Finlandia 62
KR - Corea 38
CA - Canada 34
BD - Bangladesh 31
IN - India 28
NL - Olanda 26
JP - Giappone 19
UA - Ucraina 16
AT - Austria 15
AR - Argentina 13
TR - Turchia 12
ES - Italia 11
PL - Polonia 10
ID - Indonesia 9
ZA - Sudafrica 9
BJ - Benin 8
NG - Nigeria 8
TG - Togo 8
IQ - Iraq 7
SA - Arabia Saudita 7
AU - Australia 5
CZ - Repubblica Ceca 5
BE - Belgio 4
CH - Svizzera 4
JO - Giordania 4
LT - Lituania 4
MX - Messico 4
DZ - Algeria 3
EC - Ecuador 3
LB - Libano 3
NO - Norvegia 3
PE - Perù 3
PK - Pakistan 3
PT - Portogallo 3
UZ - Uzbekistan 3
VE - Venezuela 3
AM - Armenia 2
AZ - Azerbaigian 2
CO - Colombia 2
GR - Grecia 2
IR - Iran 2
JM - Giamaica 2
KZ - Kazakistan 2
NP - Nepal 2
PY - Paraguay 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GI - Gibilterra 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.093
Città #
Moscow 312
Ashburn 305
Dallas 261
Singapore 259
Chandler 181
San Jose 167
Hong Kong 111
Southend 91
Dublin 86
Verona 74
The Dalles 65
Beijing 63
Munich 63
Ho Chi Minh City 52
Los Angeles 45
New York 38
Woodbridge 33
Jacksonville 32
Helsinki 30
Council Bluffs 27
Turku 25
Hanoi 24
Jinan 23
São Paulo 21
Buffalo 20
Lawrence 20
London 20
Princeton 20
Tianjin 20
Milan 19
Wilmington 19
Frankfurt am Main 18
Rome 18
Orem 15
Tokyo 15
Toronto 15
Atlanta 14
Taiyuan 14
Montreal 13
Santa Clara 13
Columbus 12
Sindelfingen 12
Changsha 11
Seattle 11
Amsterdam 10
Bologna 10
Da Nang 10
Denver 10
Houston 10
Kent 10
Shenyang 10
Chicago 9
Haikou 9
Nuremberg 9
Redondo Beach 9
Stockholm 9
Washington 9
Barnet 8
Cotonou 8
Hebei 8
Lomé 8
Marseille 8
Redwood City 8
Taizhou 8
Abuja 7
Hangzhou 7
Jakarta 7
Johannesburg 7
Monza 7
Phoenix 7
Vienna 7
Warsaw 7
Chennai 6
Madrid 6
Nanchang 6
Nanjing 6
Ningbo 6
Paris 6
Rio de Janeiro 6
Ann Arbor 5
Boston 5
City of London 5
Fairfield 5
Fuzhou 5
Guangzhou 5
Jiaxing 5
Nürnberg 5
Riyadh 5
San Francisco 5
Seoul 5
Trento 5
Treviso 5
Turin 5
Amman 4
Brasília 4
Brooklyn 4
Catania 4
Dhaka 4
Lappeenranta 4
Mumbai 4
Totale 3.083
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 317
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 292
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 252
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 235
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 232
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 205
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 203
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 193
Plasma Interleukin-8 is a biomarker for TAK1 activation and predicts resistance to nanoliposomal irinotecan in patients with gemcitabine-refractory pancreatic cancer 184
Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer 179
Modulating TAK1 expression inhibits YAP and TAZ oncogenic functions in pancreatic cancer 175
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients 173
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients 163
Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group 159
Targeting KRAS: The Elephant in the Room of Epithelial Cancers 158
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion 155
Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma 148
Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer 146
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial 138
Pemigatinib, a potent inhibitor of FGFRs for the treatment of cholangiocarcinoma 136
Electronic Medical Record-Assisted Telephone Follow-Up of Breast Cancer Survivors During the COVID-19 Pandemic: A Single Institution Experience 136
Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports 133
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer 125
Population pharmacokinetics and exposure-overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cancer 118
Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear 115
Safety and activity of the TGF beta receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer 110
Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study 104
Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials 104
Perioperative NALIRIFOX in Patients with Resectable Pancreatic Ductal Adenocarcinoma: An Updated Analysis of Survival and Response Biomarkers from the Phase II nITRO Trial. 98
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study 88
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma 87
Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter study 84
Totale 5.145
Categoria #
all - tutte 18.111
article - articoli 17.927
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 184
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.222


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022222 16 87 8 17 1 5 1 13 6 3 11 54
2022/2023492 25 67 34 79 38 130 3 26 64 8 12 6
2023/2024423 7 25 28 34 33 66 69 37 9 23 76 16
2024/2025816 40 37 38 127 30 34 62 40 86 42 112 168
2025/20262.698 144 114 256 413 670 187 268 123 227 181 48 67
2026/202723 23 0 0 0 0 0 0 0 0 0 0 0
Totale 5.145